{
    "2020-09-13": [
        [
            {
                "time": "2020-09-15",
                "original_text": "Pfizer CEO Says Its Coronavirus Drug Will Be Ready by End of 2020",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "Coronavirus",
                        "Drug",
                        "Ready",
                        "End",
                        "2020"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "Pfizer CEO: Coronavirus vaccine could be distributed in U.S. by end of year",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "Coronavirus",
                        "vaccine",
                        "distributed",
                        "U.S.",
                        "end",
                        "year"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "U.S. Cases Steady With Deaths Heading for 200,000: Virus Update",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Cases",
                        "Steady",
                        "Deaths",
                        "200,000",
                        "Virus",
                        "Update"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical Trial",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "Increase",
                        "Size",
                        "Coronavirus",
                        "Vaccine",
                        "Clinical",
                        "Trial"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause",
                "features": {
                    "keywords": [
                        "Surefire",
                        "Vaccine",
                        "Winner",
                        "AstraZeneca",
                        "COVID-19",
                        "Trial",
                        "Pause"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "Pfizer, BioNTech Propose Expansion Of Phase 3 Covid-19 Vaccine Trial",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "Propose",
                        "Expansion",
                        "Phase",
                        "3",
                        "Covid-19",
                        "Vaccine",
                        "Trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "What If More Than One Company Wins the Coronavirus Vaccine Race?",
                "features": {
                    "keywords": [
                        "More",
                        "Than",
                        "One",
                        "Company",
                        "Wins",
                        "Coronavirus",
                        "Vaccine",
                        "Race"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "3 Best Coronavirus Stocks to Watch in September",
                "features": {
                    "keywords": [
                        "3",
                        "Best",
                        "Coronavirus",
                        "Stocks",
                        "Watch",
                        "September"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}